BioCentury
ARTICLE | Company News

MediQuest's MQX-503 gets Priority Review

June 26, 2008 1:01 AM UTC

FDA accepted for filing and granted Priority Review to an NDA from MediQuest (Bothell, Wash.) for MQX-503 to treat Raynaud's disease, a circulatory disorder that causes extremities to become cold, pai...